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measures and glucose metabolism in infertile women 
with different ovarian reserve status
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Department of Obstetrics and Gynaecology, Hitit University Faculty of Medicine, Corum, Turkey
Abstract 
Introduction: Granulin (GRN) is an adipokine with proinflammatory features, which plays important role in glucose metabolism and insulin 
resistance pathogenesis. It has been reported that granulin precursors were localised in developing follicles in animal studies. The purpose 
of this study was to evaluate the association of granulin levels with anthropometric features, glucose metabolism, and ovarian reserve. 
Material and methods: A total of 109 infertile women were included in this cross-sectional, prospective study, who attended a tertiary 
clinic. All participants were categorised into diminished ovarian reserve (DOR) and normal ovarian reserve groups (NOR), in accordance 
with Bologna criteria. The demographic characteristics, including age, BMI, waist-hip circumferences, and biochemical parameters, were 
recorded. Serum granulin level was determined by enzyme-linked immunosorbent assay. 
Results: No significant difference was observed in the GRN levels (p = 0.229) between the groups. There was a positive correlation between 
GRN levels and BMI, WC, HC, and 75 g oral glucose tolerance values in NOR group (p < 0.01, p < 0.05, p < 0.01, and p < 0.05, respectively). 
Conclusions: Our results suggest that granulin is associated with anthropometric features in infertile patients and might be an important 
indicator of obesity and impaired glucose metabolism. Elevated levels of granulin may have a diabetogenic effect and predispose women 
to high glucose levels. (Endokrynol Pol 2019; 70 (3): 255–259)
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Introduction
Obesity and excessive body weight may affect repro-
ductive health with different mechanisms. In numerous 
studies it was demonstrated that obesity is associated 
with poor in vitro fertilisation (IVF) outcomes [1]. It 
also had a relationship with dyslipidaemia and insulin 
resistance, as important components of the metabolic 
syndrome [2]. Furthermore, all of these factors were re-
lated with low-grade chronic inflammation process and 
can lead to cardiovascular diseases [3]. In a recent study, 
the authors reported that cardiovascular risk markers 
were increased in patients with diminished ovarian 
reserve [4]. Decreased oestrogen production due to 
loss of ovarian functions may increase dyslipidaemia 
and contribute to adverse effects in glucose and insulin 
metabolism, body fat distribution, and dysfunction in 
vascular endothelium [5].
Granulin (GRN), also known as acrogranin and 
proepithelin, is an adipokine with proinflammatory 
features. It is thought that elevation of circulating levels 
may be an important indicator in the development of 
chronic inflammatory process seen in type 2 diabe-
tes and obesity [6]. It has complex physiological and 
pathological functions in various conditions including 
wound healing, tissue remodelling, progression of cell 
cycle, breast and gynaecological malignancies, and 
neurodegenerative disorders [7, 8]. In several animal 
studies it was reported that this glycoprotein pos-
sessed oocyte-specific expression, and its precursors 
were localised in granulosa cells in developing follicles 
[9]. In a recent study the authors stated that elevated 
progranulin levels are associated with obesity in in-
fertile women, and progranulin may be a promising 
therapeutic target to prevent obesity and infertility [10].
As an important adipokine with proinflammatory 
features and oocyte-specific expression in follicles, 
we hypothesise that GRN may be associated with 
glucose metabolism and ovarian reserve in infertile 
patients. The purpose of this study was to evaluate the 
levels of granulin in non-polycystic infertile patients 
and to analyse the relationship between GRN and an-
thropometric features, glucose metabolism, and ovarian 
reserve status.
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samples were analysed on a daily basis for E2, FSH, and LH using 
electrochemiluminescence immunoassay (ECLIA) method with 
an auto-analyser (Cobas 6000, E 601 Roche Diagnostics, GmbH, 
Mannheim, Germany). AMH samples were measured by the same 
method with an auto-analyser (Cobas 6000, E 601 Roche Diagnostics, 
GmbH, Mannheim, Germany). The GRN levels were measured using 
enzyme-linked immunosorbent assay (ELISA) method and granulin 
assay kits (Biotek Synergy HT, Cloud-Clone Corp., Houston, USA). 
Comparisons and correlation analyses of all data were performed.
Statistical analyses
All data analyses were performed using SPSS (Statistical Packages 
for the Social Sciences) software, version 22 (SPSS Inc., Chicago, 
USA). The Kolmogorov-Smirnov and Shapiro-Wilk tests were used 
to test normality of distribution. Continuous parameters were pre-
sented as mean ± standard deviation (SD). Continuous variables 
were compared using independent samples t-test due to normally 
distributed data. Pearson or Spearman correlation analysis, where 
appropriate, was used to test whether granulin showed any sig-
nificant linear relationship with other study parameters. A p value 
less than 0.05 was considered as statistically significant.
Results
Eighty-four women with NOR and 25 women with 
DOR were included in this study. The demographic and 
anthropometric characteristics are shown in Table I. As 
expected, the mean age of the DOR group was higher 
than the mean age of the control group (37.4 vs. 30.0, 
p < 0.001). There was no significant difference between 
the two groups for the anthropometric features, includ-
ing BMI, WC, HC, and WHR (p > 0.05, for all). While 
serum E2 and LH levels were comparable between 
the groups, higher FSH and lower AMH levels were 
observed in the DOR group (7.21 ± 1.89 vs. 9.15 ± 2.68 
and 2.93 ± 1.85 vs. 1.38 ± 2.12, p < 0.001, respectively). 
No significant difference was observed between the 
GRN levels (p = 0.229) in both groups.
Material and methods
The cross-sectional study was planned to be carried out at the Hitit 
University Reproductive Health Centre between January 2016 and 
September 2016. This study was approved by the Ethics Committee 
of Ankara Numune Training and Research Hospital and conducted 
in accordance with the institutional guidelines and Helsinki declara-
tion (reference number: E–15–563). Informed consent was obtained 
from each of the participants immediately prior to the study.
A total of 109 women seeking fertility assistance were enrolled 
in this prospective study. In the first step, women with any fore-
known systemic chronic diseases (diabetes mellitus, autoimmune 
and inflammatory diseases), history of pelvic surgery, chemora-
diotherapy due to malignancies, current smoking, and drug use 
that may affect ovarian reserve were excluded. Subsequently, 
women with PCOS, which may affect anthropometric features 
and glucose metabolism, were not included in the study. The 
diagnosis of PCOS was based on the recent Amsterdam ESHRE/
ASRM proposal [11].
The participant women who met the inclusion criteria were divided 
into two groups according to their ovarian status, as normal ovarian 
reserve (NOR) and diminished ovarian reserve (DOR) groups. The 
diagnosis of DOR was based on the Bologna criteria of the ESHRE 
consensus [12]. At least two of the following three characteristics 
were needed to diagnose the patient as DOR; (i) advanced maternal 
age (≥ 40 years) or any other risk factor for poor ovarian response; 
(ii) a previous poor response history (≤ 3 oocytes with a conven-
tional stimulation protocol); (iii) an abnormal ovarian reserve 
test (i.e. antral follicle counting < 5–7 follicles or anti-Mullerian 
hormone levels < 0.5–1.1 ng/dL). 
First, all anthropometric measurements including height, weight, 
waist circumference (WC), hip circumferences (HC), and waist-hip 
circumference ratio (WHR) were performed by the same observer 
using the same method with the same scale. Body mass index 
(BMI) was calculated as weight (kg)/height2 (m2). Both groups were 
compared in terms of their anthropometric features.
For assessment of serum follicle stimulating hormone (FSH), luteinis-
ing hormone (LH), oestradiol (E2), anti-Mullerian hormone (AMH) 
and granulin levels, venous blood samples (5 ml) were collected from 
the participants in the morning, after an approximately eight-hour 
fasting period on their early follicular phase. Following collection, 
samples were centrifuged at 3000 rpm for 20 minutes, and separated 
plasma for AMH and GRN were stored at –80°C until analysis. The 
Table I. Baseline anthropometric and biochemical characteristics of the participant women
DOR group (n = 25) NOR group (n = 84) p 
Age [years] 37.4 ± 3.4 30.0 ± 5.7 0.000**
BMI [kg/m2] 25.5 ± 4.3 26.6 ± 5.1 0.443
WC [cm] 89.6 ± 9.1 89.8 ± 11.7 0.947
HC [cm] 105.1 ± 6.7 105.4 ± 10.4 0.878
WHR 0.9 ± 0.1 0.9 ± 0.1 0.789
FSH [IU/mL] 9.2 ± 2.7 7.2 ± 1.9 0.001**
LH [IU/mL] 6.7 ± 3.0 5.8 ± 2.1 0.240
E2 [pg/mL] 47.7 ± 25.8 46.8 ± 26.1 0.957
AMH [ng/mL] 1.4 ± 2.1 2.9 ± 1.9 0.000**
Fasting glucose [mg/dL] 99.3 ± 39.9 91.8 ± 12.2 0.773
75-g OGTT [mg/dL] 129.1 ± 79.3 105.1 ± 32.4 0.119
Granulin [ng/mL] 3.1 ± 1.2 2.7 ± 1.1 0.141
DOR — diminished ovarian reserve; NOR — normal ovarian reserve; BMI — body mass index; WC — waist circumference; HC — hip circumference;  
WHR — waist–hip ratio; FSH — follicle-stimulating hormone; LH — luteinising hormone; E2 — oestradiol; AMH — anti-Mullerian hormone; OGTT — oral glucose 
tolerance test. Values are expressed as mean ± SD; **p < 0.01
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For each group, the relationship of GRN with other 
parameters were analysed with Spearman-Brown cor-
relation, and the results are shown in Table II. There 
was a weak positive correlation between GRN levels 
and BMI, WC, and HC in the NOR group (r = 0.288; 
p < 0.01, r = 0.324; p < 0.05 and r = 0.266; p < 0.01, 
respectively). However, no significant correlation 
was found between these parameters in patients 
with DOR (r = –0.066; p > 0.05, r = 0.119; p > 0.05, 
r = –0.339; p > 0.05). In addition, there was a weak 
positive correlation between serum granulin concen-
tration and 75 g oral glucose tolerance (OGTT) values 
in the NOR group (r = 0.254; p < 0.05). However, in 
the DOR group, no significant correlation was found 
between glucose tolerance test results and GRN levels 
(r = 0.167; p > 0.05).
The correlation analysis of the GRN levels with the 
parameters in the study independent from ovarian 
reserve status is shown in Table III. A significant weak 
positive correlation was found between GRN and 
BMI, WC, WHR, and 75-g OGTT (r = 0.191; p < 0.05, 
r = 0.257; p < 0.01, r = 0.220; p < 0.01, r = 0.228; 
p < 0.05, respectively). No significant correlation was 
found between serum GRN level and age.
Discussion
In the present study, we focused on serum GRN con-
centrations, a novel adipokine with inflammatory and 
endocrine properties, and its association with anthro-
pometric features, and glucose metabolism in women 
with non-polycystic infertile patients. 
Granulin is a prominent adipokine and its associa-
tion with reproductive biology has been indicated in 
several studies. Suzuki et al. reported that GRN acted 
as an autocrine stimulator during the oocyte matura-
tion process [9]. In another animal study, Vendola et 
al. suggested that GRN may augment early follicle 
development, similarly to the androgenic effect in 
monkeys [13]. Other studies also suggest that GRN 
and its precursors play a major role in the development 
of ovarian premature follicle [14]. Although GRN was 
thought to be effective on ovarian folliculogenesis and 
embryogenesis, we did not find a significant correlation 
between granulin and ovarian reserve tests. Similar to 
our results, Ersoy et al. also did not find any association 
between GRN and FSH levels in patients with prema-
ture ovarian failure (POF) [15]. The authors therefore 
suggested that the association of GRN with ovarian 
failure may be encountered as a result of POF, regardless 
of the impact of FSH or ovarian reserve tests.
In our study, we found a significant relationship 
between GRN and BMI, WHR, and glucose tolerance 
test regardless of ovarian reserve status. Recently, it 
was found that in peripheral tissues, excessive limits 
of GRN are closely linked to obesity and insulin resis-
tance [16]. In another study, the authors reported that 
circulating GRN levels were positively correlated with 
body mass index and glucose levels [17]. As a result, 
it was thought that levels of this adipokine might in-
crease due to uncontrolled expansion in adipose, and 
this condition might provoke obesity by stimulating 
angiogenesis and promoting growth in target tissue 
[16]. Although measurement of GRN levels from these 
studies seems useful in predicting inflammation and 
obesity-related metabolic diseases, further studies are 
Table II. Correlation analysis of granulin with other 
parameters according to ovarian reserve status
 
Granulin levels
DOR group NOR group
Age [years] 0.301 0.033
BMI [kg/m2] 0.066 0.288**
WC [cm] 0.119 0.324**
HC [cm] –0.339 0.266*
WHR 0.383 0.206
FSH [IU/mL] 0.186 –0.113
LH [IU/mL] 0.055 –0.171
E2 [pg/mL] 0.185 –0.091
AMH [ng/mL] –0.388 0.053
75-g OGTT [mg/dL] 0.168 0.254*
DOR — diminished ovarian reserve; NOR — normal ovarian reserve;  
BMI — body mass index; WC — waist circumference; HC — hip circumference; 
WHR — waist–hip ratio; FSH — follicle-stimulating hormone; LH — luteinising 
hormone; E2 — oestradiol; AMH — anti-Mullerian hormone; OGTT — oral 
glucose tolerance test
Table III. Correlation analysis of granulin levels with study 
parameters
r p
Age [years] 0.154 0.111
BMI [kg/m2] 0.191 0.047*
WC [cm] 0.257 0.007**
HC [cm] 0.145 0.134
WHR 0.220 0.022*
FSH [IU/mL] 0.021 0.830
LH [IU/mL] –0.076 0.432
E2 [pg/mL] –0.019 0.848
AMH [ng/mL] –0.107 0.270
75-g OGTT [mg/dL] 0.228 0.017*
BMI — body mass index; WC — waist circumference; HC — hip circumference; 
WHR — waist–hip ratio; FSH — follicle-stimulating hormone; LH — luteinising 
hormone; E2: — oestradiol; AMH — anti-Mullerian hormone; OGTT — oral 
glucose tolerance test. *p < 0.05, **p < 0.01
258
O
R
IG
IN
A
L
 P
A
P
E
R
Granulin and glucose metabolism Ozgur Kan, Umit Gorkem
needed to determine if measuring GRN levels will be 
useful as a reliable biomarker of metabolic syndrome.
Interestingly, the present results also demonstrated 
that serum GRN levels did not have any relationship 
with age, regardless of ovarian reserve status. Similar 
to our results, Ersoy et al. also did not find a correla-
tion between age and serum GRN levels [15]. When 
the relationship between GRN levels and age was ex-
amined according to ovarian reserve status, there was 
a significant relationship between age and granulin in 
normoresponder patients. Considering that patients 
with normal ovarian reserve are younger than poor 
responders, it is thought that granulin may be involved 
in ovarian response physiology, especially in early age. 
As shown in plants, GRN levels gradually decrease 
with aging [18]. In light of these findings, Ersoy et 
al. proposed that GRN levels may be an indicator for 
senescence of the human ovary, rather than human 
life senescence [15]. However, the role of GRN in the 
mechanism of this topic remains unclear.
The relationship between GRN and PCOS and its 
possible metabolic effects has been previously evaluated 
in many studies. It is known that insulin resistance plays 
an important role in PCOS pathophysiology. In a recent 
study from Turkey, higher progranulin levels in women 
with PCOS were found compared with non-PCOS 
patients [19]. The authors proposed that cysteine-rich 
growth factors like progranulin may cause excessive 
early follicular growth as androgens. Zhou et al. also 
investigated the possible effects of progranulin in PCOS 
patients and found higher progranulin levels in follicu-
lar fluid [20]. These findings suggest that progranulin 
may be used as a marker for insulin resistance in the 
follicular compartment in polycystic patients.
The strengths of our study include its prospective 
and multivariable design, being the first to compare 
serum GRN levels in patients with different ovarian 
reserve status, and evaluating the effects of GRN on 
glucose metabolism and anthropometric features re-
gardless of ovarian reserve. Our findings are limited 
by its relatively small sample size, and further studies 
with larger groups are warranted. In addition, it is 
possible to criticise why insulin level measurements 
and lipid profile-related values  are not investigated 
in order to calculate homeostatic model assessment 
for the insulin resistance (HOMA-IR) index. Because 
these data were not investigated, the feasibility of GRN 
levels in predicting cardiovascular risk factors could 
not be investigated.
Conclusions
We demonstrated a positive correlation between serum 
GRN concentration and anthropometric measures in 
the NOR group. However, our findings did not support 
any correlation of GRN with these measures in women 
with DOR. Interestingly, there was a positive correlation 
between serum GRN level and 75-g OGTT only in the 
NOR group. In other words, it is possible to propose 
that elevated GRN levels may have a diabetogenic ef-
fect and predispose women to high serum glucose lev-
els. Further large-sized prospective studies are needed 
to elucidate the role of GRN on glucose metabolism.
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